Cargando…
COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
Various vaccine platforms are geared against COVID-19 vaccine development to produce immunogens in cells. To design a recombinant protein-based COVID-19 vaccine, Vaxine pty Ltd used computer models of the spike protein and its human receptor, ACE2, to identify how the virus infects human cells. Base...
Autores principales: | Chavda, Vivek P., Vora, Lalitkumar K., Vihol, Disha R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V. on behalf of Zhejiang Chinese Medical University.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351577/ http://dx.doi.org/10.1016/j.ccmp.2021.100004 |
Ejemplares similares
-
Joint COVAX statement on the equal recognition of vaccines
Publicado: (2021) -
COVAX calls for urgent action to close vaccine equity gap
Publicado: (2022) -
COVAX delivers its 1 billionth COVID-19 vaccine dose
Publicado: (2022) -
The Vaccine World of COVID-19: India’s Contribution
por: Chavda, Vivek P., et al.
Publicado: (2022) -
Covax announces new agreement, plans for first deliveries
Publicado: (2021)